Page last updated: 2024-11-08

biguanides and Hypoparathyroidism

biguanides has been researched along with Hypoparathyroidism in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Langslet, A1
Olsen, I1
Lie, SO1
Lokken, P1

Other Studies

1 other study available for biguanides and Hypoparathyroidism

ArticleYear
Chlorhexidine treatment of oral candidiasis in seriously diseased children.
    Acta paediatrica Scandinavica, 1974, Volume: 63, Issue:6

    Topics: Administration, Topical; Adolescent; Biguanides; Candidiasis, Oral; Child; Child, Preschool; Chronic

1974